Cardiol Therapeutics (CRDL) Free Cash Flow (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Free Cash Flow came in at -$5.4 million in Q1 2026, down 9.44% YoY from -$6.0 million in Q1 2025, and down 44.11% on a QoQ basis from -$3.8 million in Q4 2025.
Cardiol Therapeutics (CRDL) Free Cash Flow (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of Free Cash Flow data on file, last reported at -$5.4 million in Q1 2026.
- Quarterly Free Cash Flow fell 9.44% year-over-year to -$5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$17.5 million (up 3.57% YoY) and the FY2025 annual result came in at -$17.1 million, up 4.63% from the prior year.
- Free Cash Flow slipped to -$5.4 million in Q1 2026, from -$3.8 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$1.3 million in Q3 2022 to a low of -$9.3 million in Q4 2022.
- A 5-year average of -$4.7 million and a median of -$4.8 million in 2023 frame the typical range for Free Cash Flow.
- The widest YoY moves for Free Cash Flow: up 74.57% in 2022, down 191.99% in 2022.
- Tracing CRDL's Free Cash Flow over 5 years: stood at -$9.3 million in 2022, then surged by 48.1% to -$4.8 million in 2023, then climbed by 16.65% to -$4.0 million in 2024, then grew by 6.21% to -$3.8 million in 2025, then plunged by 44.11% to -$5.4 million in 2026.
- The last three Free Cash Flow figures came in at -$5.4 million (Q1 2026), -$3.8 million (Q4 2025), and -$5.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Cardiol Therapeutics | 213.21 Mn | 194.35 Mn | - | -3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.45 Mn |
| Mar 31, 2026 | -5.45 Mn |
| Dec 31, 2025 | -3.78 Mn |
| Dec 31, 2025 | -3.78 Mn |
| Sep 30, 2025 | -5.03 Mn |
| Sep 30, 2025 | -5.03 Mn |
| Jun 30, 2025 | -3.28 Mn |
| Jun 30, 2025 | -3.28 Mn |
| Mar 31, 2025 | -4.98 Mn |
| Mar 31, 2025 | -4.98 Mn |
| Dec 31, 2024 | -4.03 Mn |
| Dec 31, 2024 | -4.03 Mn |
| Sep 30, 2024 | -5.69 Mn |
| Sep 30, 2024 | -5.69 Mn |
| Jun 30, 2024 | -3.49 Mn |
| Jun 30, 2024 | -3.49 Mn |
| Mar 31, 2024 | -5.13 Mn |
| Mar 31, 2024 | -5.13 Mn |
| Dec 31, 2023 | -4.84 Mn |
| Dec 31, 2023 | -4.84 Mn |